• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron

cafead

Administrator
Staff member
  • cafead   Jul 14, 2024 at 10:22: PM
via The recent U.S. Supreme Court decision to overturn the Chevron doctrine could open the door to more challenges of Food and Drug Administration regulations, including the agency’s controversial rule on lab-developed tests.

article source
 

<